These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
430 related items for PubMed ID: 26251078
1. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cetin MS, Ozcan Cetin EH, Aras D, Topaloglu S, Temizhan A, Kisacik HL, Aydogdu S. Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078 [Abstract] [Full Text] [Related]
2. Platelet to Lymphocyte Ratio as a Prognostic Marker of In-Hospital and Long-Term Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction. Ozcan Cetin EH, Cetin MS, Aras D, Topaloglu S, Temizhan A, Kisacik HL, Aydogdu S. Angiology; 2016 Apr; 67(4):336-45. PubMed ID: 26101368 [Abstract] [Full Text] [Related]
3. Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction. Viveiros Monteiro A, Ramos R, Fiarresga A, de Sousa L, Cacela D, Patrício L, Bernardes L, Soares C, Cruz Ferreira R. Herz; 2017 Apr; 42(2):186-193. PubMed ID: 27363417 [Abstract] [Full Text] [Related]
4. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Zhang JW, Zhou YJ, Cao SJ, Yang Q, Yang SW, Nie B. Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666 [Abstract] [Full Text] [Related]
5. Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI. Yamac AH, Sevgili E, Kucukbuzcu S, Nasifov M, Ismailoglu Z, Kilic E, Ercan C, Jafarov P, Uyarel H, Bacaksiz A. Herz; 2015 Sep; 40(6):912-20. PubMed ID: 25911051 [Abstract] [Full Text] [Related]
10. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction). Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S. JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734 [Abstract] [Full Text] [Related]
11. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy). Kirtane AJ, Sandhu P, Mehran R, McEntegart M, Cristea E, Brener SJ, Xu K, Fahy M, Généreux P, Wessler JD, Stone GW. Am J Cardiol; 2014 Jan 01; 113(1):36-43. PubMed ID: 24169019 [Abstract] [Full Text] [Related]
12. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Kurtul A, Yarlioglues M, Murat SN, Ergun G, Duran M, Kasapkara HA, Demircelik MB, Cetin M, Ocek AH. Am J Cardiol; 2014 Aug 01; 114(3):342-7. PubMed ID: 24948493 [Abstract] [Full Text] [Related]
13. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis. Arzamendi D, Ly HQ, Tanguay JF, Armero S, Jilaihawi H, Gallo R, Ibrahim R, L'Allier P, Blondeau L, Gosselin G, Gregoire J, Doucet S. Catheter Cardiovasc Interv; 2013 Aug 01; 82(2):193-200. PubMed ID: 21805615 [Abstract] [Full Text] [Related]
17. Cardiac troponin elevation pattern in patients undergoing a primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: characterization and relationship with cardiovascular events during hospitalization. Buber J, Laish-Farkash A, Koren-Morag N, Fefer P, Segev A, Hod H, Matetzky S. Coron Artery Dis; 2015 Sep 01; 26(6):503-9. PubMed ID: 26061436 [Abstract] [Full Text] [Related]
18. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention]. Wang CH, Jin XF, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Liu ZY, Xie HZ. Zhonghua Yi Xue Za Zhi; 2011 Nov 15; 91(42):3003-6. PubMed ID: 22333029 [Abstract] [Full Text] [Related]